Literature DB >> 22980312

Race and gender variation in the QT interval and its association with mortality in patients with coronary artery disease: results from the Duke Databank for Cardiovascular Disease (DDCD).

Eric S Williams1, Kevin L Thomas, Samuel Broderick, Linda K Shaw, Eric J Velazquez, Sana M Al-Khatib, James P Daubert.   

Abstract

BACKGROUND: In several studies, prolongation of the corrected QT (QTc) interval has been associated with an increased risk of cardiac events. However, data on race and gender variation in the QTc and its associated risk of death are lacking.
METHODS: We prospectively followed 19,252 subjects who underwent cardiac catheterization and had at least 1 native coronary artery stenosis ≥75%. Automated QTc measurements were obtained from a baseline electrocardiogram.
RESULTS: The mean age of the population was 62.4 years, with 35% being female and 20% being black. The QTc varied by gender and race (417.9 ± 34.4 ms in men and 433.4 ± 33.6 ms in women, 422.1 ± 34.3 ms in whites and 428.1 ± 36.9 ms in blacks; P < .0001 for both). Risk factors most strongly associated with a prolonged QTc were lower ejection fraction, higher diastolic blood pressure, history of myocardial infarction, and lower glomerular filtration rate. Black race and female gender were also independently associated with a prolonged QTc, after adjustment for cardiac risk factors. Moreover, there was an independent association between QTc and all-cause mortality (hazard ratio 1.037 per 10-ms increase, P < .0001). The increased mortality risk associated with a 10-ms increase in the QTc interval was significantly greater for men compared with women (4.6% vs 2.4%, P = .004) and slightly greater for blacks compared with other races (5.0% vs 3.3%, P = .057).
CONCLUSIONS: Among patients with coronary artery disease, QTc prolongation is independently associated with all-cause mortality. The increased mortality risk is higher for men than for women, with a trend toward higher mortality in blacks.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22980312     DOI: 10.1016/j.ahj.2012.05.024

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  20 in total

Review 1.  The year of 2012 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-07       Impact factor: 1.468

2.  Population Prevalence and Correlates of Prolonged QT Interval: Cross-Sectional, Population-Based Study From Rural Uganda.

Authors:  Itai M Magodoro; Alfred J Albano; Rahul Muthalaly; Bruce Koplan; Crystal M North; Dagmar Vořechovská; Jordan Downey; John Kraemer; Martino Vaglio; Fabio Badilini; Bernard Kakuhire; Alexander C Tsai; Mark J Siedner
Journal:  Glob Heart       Date:  2018-12-21

3.  The QT interval is associated with incident cardiovascular events: the MESA study.

Authors:  Roy Beinart; Yiyi Zhang; João A C Lima; David A Bluemke; Elsayed Z Soliman; Susan R Heckbert; Wendy S Post; Eliseo Guallar; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2014-11-10       Impact factor: 24.094

4.  Hydroalcoholic Extract of Sechium edule Fruits Attenuates QT Prolongation in High Fat Diet-Induced Hyperlipidemic Mice.

Authors:  Firdous Sayed Mohammed; Arya Ghosh; Sourav Pal; Chayan Das; Suliman Yousef Alomar; Mohsina Patwekar; Faheem Patwekar; Byong-Hun Jeon; Fahadul Islam
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-11       Impact factor: 2.650

5.  Distinctive Clinical Profile of Blacks Versus Whites Presenting With Sudden Cardiac Arrest.

Authors:  Kyndaron Reinier; Gregory A Nichols; Adriana Huertas-Vazquez; Audrey Uy-Evanado; Carmen Teodorescu; Eric C Stecker; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  Circulation       Date:  2015-07-20       Impact factor: 29.690

6.  Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Lupus Sci Med       Date:  2016-12-08

7.  QTc interval prolongation in HIV-infected patients: a case-control study by 24-hour Holter ECG recording.

Authors:  Alessandra Fiorentini; Nicola Petrosillo; Angelo Di Stefano; Stefania Cicalini; Laura Borgognoni; Evangelo Boumis; Luigi Tubani; Pierangelo Chinello
Journal:  BMC Cardiovasc Disord       Date:  2012-12-23       Impact factor: 2.298

8.  Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial.

Authors:  Lea T Drye; David Spragg; D P Devanand; Constantine Frangakis; Christopher Marano; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro; Gregory Pelton; Bruce G Pollock; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; David M Shade; Daniel Weintraub; Jerome Yesavage; Constantine G Lyketsos
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

9.  Longitudinal Community-Based Study of QT Interval and Mortality in Southeast Asians.

Authors:  Jonathan Yap; Ai Zhen Jin; Shwe Zin Nyunt; Tze Pin Ng; A Mark Richards; Carolyn S P Lam
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

10.  QT interval Independently Predicts Mortality and Heart Failure in Patients with ST-Elevation Myocardial Infarction.

Authors:  Jeng-Feng Lin; Shun-Yi Hsu; Semon Wu; Ming-Sheng Teng; Hsin-Hua Chou; Shih-Tsung Cheng; Tien-Yu Wu; Yu-Lin Ko
Journal:  Int J Med Sci       Date:  2015-11-17       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.